FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
|
Thread Tools | Display Modes |
08-03-2014, 08:34 AM | #6 | ||
|
|||
Member
|
Amantadine is a weak antagonist of the NMDA type glutamate receptor and is supposed to increase dopamine release. It didn't do anything for me. Hope you have better luck.
|
||
Reply With Quote |
|
|
Similar Threads | ||||
Thread | Forum | |||
amantadine | Traumatic Brain Injury and Post Concussion Syndrome | |||
Amantadine | Traumatic Brain Injury and Post Concussion Syndrome | |||
Amantadine | Parkinson's Disease | |||
Amantadine and PCS | Traumatic Brain Injury and Post Concussion Syndrome | |||
Amantadine | Parkinson's Disease |